Head and Neck Carcinomas Across the Age Spectrum: Epidemiology, Therapy, and Late Effects

被引:33
作者
Marcus, Karen J. [1 ]
Tishler, Roy B. [2 ]
机构
[1] Childrens Hosp Boston, Div Radiat Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA
关键词
ADVANCED NASOPHARYNGEAL CARCINOMA; EPSTEIN-BARR-VIRUS; CONCURRENT CISPLATIN-RADIOTHERAPY; RANDOMIZED TRIAL; CHILDHOOD; CANCER; CHEMOTHERAPY; CHILDREN; EXPERIENCE; SURVIVAL;
D O I
10.1016/j.semradonc.2009.09.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Carcinomas of the head and neck occur in both children and adults, but notable differences exist in their relative frequency, pathologic subtypes, etiologies, presenting symptoms, and late effects. In contrast, treatment strategies are similar depending on the disease type and distribution at the time of diagnosis. Thus, in adult patients, squamous cell carcinomas or one of its variants are the most common malignancies in the head and neck. However, in children, cancers of the head/neck are most commonly rhabdomyosarcomas, lymphomas, including Hodgkin's lymphoma, lymphoblastic lymphomas, and Burkitt's lymphoma or neuroblastoma. Epithelial cancers are unusual in the pediatric population, with the exception of nasopharyngeal carcinoma. Although nasopharyngeal carcinoma is a rare disease in children, representing less than 1% of childhood cancers, it does constitute 20%-50% of pediatric malignancies of the nasopharynx. This is one of the few malignant tumors in children that arise from the epithelium. Despite the differences between the diseases in children from that in adults, the management strategy has been based largely on the experience in adults. This review will describe the epidemiology, etiology, management, and late effects in children and adults, and offer explanations for both the similarities and differences. Semin Radiat Oncol 20:52-57 (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 34 条
[1]   Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099 [J].
Al-Sarraf, M ;
LeBlanc, M ;
Giri, PGS ;
Fu, KK ;
Cooper, J ;
Vuong, T ;
Forastiere, AA ;
Adams, G ;
Sakr, WA ;
Schuller, DE ;
Ensley, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) :1310-1317
[2]  
[Anonymous], 1997, AJCC CANC STAGING MA
[3]   Childhood nasopharyngeal carcinoma: from biology to treatment [J].
Ayan, I ;
Kaytan, E ;
Ayan, N .
LANCET ONCOLOGY, 2003, 4 (01) :13-21
[4]   Nasopharyngeal carcinoma in children: Retrospective review of 50 patients [J].
Ayan, I ;
Altun, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 35 (03) :485-492
[5]   Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta-analysis of eight randomized trials and 1753 patients [J].
Baujat, B ;
Audry, W ;
Bourhis, J ;
Chan, ATC ;
Onat, H ;
Chua, DTT ;
Kwong, DLW ;
al-Sarraf, M ;
Chi, KH ;
Hareyama, M ;
Leung, SF ;
Thephamongkhol, K ;
Pignon, JP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (01) :47-56
[6]   Age-incidence curves of nasopharyngeal carcinoma worldwide: Bimodality in low-risk populations and aetiologic implications [J].
Bray, Freddie ;
Haugen, Marion ;
Moger, Tron A. ;
Tretli, Steinar ;
Aalen, Odd O. ;
Grotmol, Tom .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (09) :2356-2365
[7]   Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma [J].
Chan, ATC ;
Leung, SF ;
Ngan, RKC ;
Teo, PML ;
Lau, WH ;
Kwan, WH ;
Hui, EP ;
Yiu, HY ;
Yeo, W ;
Cheung, FY ;
Yu, KH ;
Chiu, KW ;
Chan, DT ;
Mok, TSK ;
Yau, S ;
Yuen, KT ;
Mo, FKF ;
Lai, MMP ;
Ma, BBY ;
Kam, MKM ;
Leung, TWT ;
Johnson, PJ ;
Choi, PHK ;
Zee, BCY .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (07) :536-539
[8]   Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: Progression-free survival analysis of a phase III randomized trial [J].
Chan, ATC ;
Teo, PML ;
Ngan, RK ;
Leung, TW ;
Lau, WH ;
Zee, B ;
Leung, SF ;
Cheung, FY ;
Yeo, W ;
Yiu, HH ;
Yu, KH ;
Chiu, KW ;
Chan, DT ;
Mok, T ;
Yuen, KT ;
Mo, F ;
Lai, M ;
Kwan, WH ;
Choi, P ;
Johnson, PJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (08) :2038-2044
[9]  
Claudio PP, 2000, CANCER RES, V60, P8
[10]   Epstein-Barr virus infection. [J].
Cohen, JI .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (07) :481-492